Why the study?
Does flunarizine reduce cerebrovascular permeability to protein in rats with norepinephrine-induced acute hypertension?
Does flunarizine reduce cerebrovascular permeability to protein in rats with norepinephrine-induced acute hypertension?
Flunarizine pretreatment reduces blood-brain barrier permeability in a rat model of acute hypertension, suggesting a role for calcium in cerebral endothelial permeability.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for calcium channel blockade in hypertensive blood-brain barrier protection; prospective human studies required.
BACKGROUND AND PURPOSE: Increased cerebrovascular permeability to protein is a well-documented finding in acute and chronic hypertension. In this study, we examined the effect of pretreatment with a calcium entry blocker, flunarizine, on the increased cerebrovascular permeability to protein that develops in norepinephrine-induced acute hypertension. METHODS: Protein transfer was assessed qualitatively with Evans blue dye and quantitatively with iodine-125-labeled serum albumin. RESULTS: Brains of hypertensive rats showed increased permeability to both tracers. The number and size of the areas of Evans blue extravasation were smaller in the hypertensive groups pretreated with flunarizine intravenously. This was supported by the quantitative studies, which demonstrated a significant decrease in protein transfer in total brain of hypertensive rats pretreated with intravenous flunarizine, 1 mg/kg (p less than 0.005) and 2.5 mg/kg (p less than 0.001). Data from individual brain regions showed that pretreatment with flunarizine resulted in significant reduction of protein transfer in most brain regions. CONCLUSIONS: These data support the hypothesis that calcium plays a role in increased cerebral endothelial permeability in hypertension.
No takes yet. Share an insight, caveat, or question.
Sukriti Nag (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: